Cutler Group LP Ionis Pharmaceuticals Inc Call Options Transaction History

Cutler Group LP

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Jan 18, 2024	BUY	$43.39 - $51.63 $442,578 - $526,626	10,200 New	10,200 $15,000
Q1 2022 Apr 14, 2022	SELL	$29.88 - $37.04 $218,124 - $270,392	-7,300 Reduced 98.65%	100 $1,000
Q3 2021 Oct 26, 2021	BUY	$33.54 - $40.55 $80,496 - $97,320	2,400 Added 48.0%	7,400 $10,000
Q2 2021 Jul 19, 2021	BUY	$34.54 - $47.25 $172,700 - $236,250	5,000 New	5,000 $1,000
Q1 2021 Apr 26, 2021	SELL	$42.51 - $63.78 $42,510 - $63,780	-1,000 Closed	0 $0
Q3 2019 Oct 28, 2019	BUY	$59.06 - $72.15 $59,060 - $72,150	1,000 New	1,000 $6,000
Q2 2019 Aug 09, 2019	SELL	$62.09 - $86.14 $248,360 - $344,560	-4,000 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$52.92 - $81.17 $619,164 - $949,689	-11,700 Reduced 74.52%	4,000 $105,000
Q4 2018 Feb 05, 2019	BUY	$43.37 - $59.54 $121,436 - $166,712	2,800 Added 21.71%	15,700 $30,000
Q3 2018 Nov 07, 2018	SELL	$42.88 - $53.7 $38,592 - $48,330	-900 Reduced 6.52%	12,900 $35,000
Q2 2018 Aug 10, 2018	BUY	$40.53 - $50.7 $44,583 - $55,770	1,100 Added 8.66%	13,800 $18,000
Q1 2018 May 11, 2018	SELL	$44.08 - $55.05 $630,344 - $787,215	-14,300 Reduced 52.96%	12,700 $43,000
Q4 2017 Jan 17, 2018	SELL	$50.3 - $64.39 $467,790 - $598,827	-9,300 Reduced 25.62%	27,000 $263,000
Q3 2017 Oct 17, 2017	BUY	$45.56 - $59.57 $1.65 Million - $2.16 Million	36,300	36,300 $374,000

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.83B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.